loader
Please Wait
Applying Filters...
menu
    • menu

    Setid C1668baa Faa4 48a9 Aaf5 Cfecd196fd2f Applno 203231 Form Injectable Intravenous Dosage Eq 4mg Base 100ml - Drug Product Composition: Zoledronic Acid

    Menu

    Zoledronic Acid

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 176,069Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 203231 / DOSAGE - INJECTABLE;INTRAVENOUS - EQ 4MG BASE/100ML

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    zoledronic acid(UNII: 6XC1PAD3KF)
    (zoledronic acid anhydrous - UNII:70HZ18PH24)     		zoledronic acid anhydrous0.04mg in 1

    Inactive Ingredients

    Ingredient Name
    Cipla USA Inc.
    Dr. Reddy's Laboratories Inc
    Sagent Pharmaceuticals
    mannitol(3OWL53L36A)
    sodium chloride(451W47IQ8X)  
    SODIUM CITRATE(1Q73Q2JULR)
    WATER(059QF0KO0R)